Literature DB >> 12716016

Melatonin increases interleukin-1beta and decreases tumor necrosis factor alpha in the brain of mice infected with the Venezuelan equine encephalomyelitis virus.

Ernesto Bonilla1, Nereida Valero, Leonor Chacín-Bonilla, Héctor Pons, Yraima Larreal, Shirley Medina-Leendertz, Luz Marina Espina.   

Abstract

The effect of melatonin (MLT) on the brain levels of tumor necrosis factor alpha (TNF-alpha) and interleukin-1beta (IL-1beta) in Venezuelan equine encephalomyelitis (VEE) virus infection was determined. Brain homogenates from mice inoculated with 10 LD50 of VEE virus, untreated or treated with 500 microg MLT/kg body weight were assayed by ELISA to measure the levels of TNF-alpha and IL-1beta. MLT was injected daily starting 3 days before and continuing to 7 days after virus inoculation. Infected mice treated with MLT showed decreased levels of TNF-alpha when compared to the untreated infected mice on days 1, 3, 4, and 5 postinoculation (P < 0.001). In contrast, IL-1beta levels increased from days 1 to 5 in the infected mice treated with MLT when compared with the untreated infected animals (P < 0.01). The results suggest that the protective effect of MLT on the VEE virus infection could be due, among other factors, to a decrease in TNF-alpha synthesis along with an increase in the production of IL-1beta.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12716016     DOI: 10.1023/a:1022897314108

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   4.414


  55 in total

1.  Melatonin prolongs survival of immunodepressed mice infected with the Venezuelan equine encephalomyelitis virus.

Authors:  E Bonilla; C Rodón; N Valero; H Pons; L Chacín-Bonilla; J Garcia Tamayo; Z Rodríguez; S Medina-Leendertz; F Añez
Journal:  Trans R Soc Trop Med Hyg       Date:  2001 Mar-Apr       Impact factor: 2.184

2.  Tumor necrosis factor inhibits neurite outgrowth and branching of hippocampal neurons by a rho-dependent mechanism.

Authors:  Harald Neumann; Rudiger Schweigreiter; Toshihide Yamashita; Katja Rosenkranz; Hartmut Wekerle; Yves-Alain Barde
Journal:  J Neurosci       Date:  2002-02-01       Impact factor: 6.167

Review 3.  Nervous tissue as an immune compartment: the dialect of the immune response in the CNS.

Authors:  Z Fabry; C S Raine; M N Hart
Journal:  Immunol Today       Date:  1994-05

4.  Neurodegeneration induced by MoMuLV-ts1 and increased expression of Fas and TNF-alpha in the central nervous system.

Authors:  W Choe; G Stoica; W Lynn; P K Wong
Journal:  Brain Res       Date:  1998-01-01       Impact factor: 3.252

5.  Melatonin induces changes to serum cytokines in mice infected with the Venezuelan equine encephalomyelitis virus.

Authors:  Nereida Valero; Ernesto Bonilla; Héctor Pons; Leonor Chacin-Bonilla; Florencio Añez; Luz Marina Espina; Shirley Medina-Leendertz; Jorge García Tamayo
Journal:  Trans R Soc Trop Med Hyg       Date:  2002 May-Jun       Impact factor: 2.184

6.  Arachidonic acid lipoxygenation may mediate interleukin-1 stimulation of nerve growth factor secretion in astroglial cultures.

Authors:  M Carman-Krzan; B C Wise
Journal:  J Neurosci Res       Date:  1993-02-01       Impact factor: 4.164

Review 7.  The biological properties of interleukin-1.

Authors:  C A Dinarello
Journal:  Eur Cytokine Netw       Date:  1994 Nov-Dec       Impact factor: 2.737

8.  Effect of neuropeptides on production of inflammatory cytokines by human monocytes.

Authors:  M Lotz; J H Vaughan; D A Carson
Journal:  Science       Date:  1988-09-02       Impact factor: 47.728

9.  Activation of human monocytes by the pineal hormone melatonin.

Authors:  K M Morrey; J A McLachlan; C D Serkin; O Bakouche
Journal:  J Immunol       Date:  1994-09-15       Impact factor: 5.422

Review 10.  T-helper-2 lymphocytes as a peripheral target of melatonin.

Authors:  G J Maestroni
Journal:  J Pineal Res       Date:  1995-03       Impact factor: 13.007

View more
  11 in total

Review 1.  A review of the multiple actions of melatonin on the immune system.

Authors:  Antonio Carrillo-Vico; Juan M Guerrero; Patricia J Lardone; Russel J Reiter
Journal:  Endocrine       Date:  2005-07       Impact factor: 3.633

2.  Melatonin decreases nitric oxide production, inducible nitric oxide synthase expression and lipid peroxidation induced by Venezuelan encephalitis equine virus in neuroblastoma cell cultures.

Authors:  Nereida Valero; Luz Marina Espina; Jesus Mosquera
Journal:  Neurochem Res       Date:  2006-06-28       Impact factor: 3.996

Review 3.  Metabolic effects of melatonin on oxidative stress and diabetes mellitus.

Authors:  Shigeru Nishida
Journal:  Endocrine       Date:  2005-07       Impact factor: 3.633

4.  Melatonin decreases brain apoptosis, oxidative stress, and CD200 expression and increased survival rate in mice infected by Venezuelan equine encephalitis virus.

Authors:  Milagros Montiel; Ernesto Bonilla; Nereida Valero; Jesús Mosquera; Luz M Espina; Yasmir Quiroz; Melchor Álvarez-Mon
Journal:  Antivir Chem Chemother       Date:  2016-08-08

5.  Antagonistic effect of luzindole in mice treated with melatonin during the infection with the venezuelan equine encephalomyelitis virus.

Authors:  Nereida Valero; Anaís Nery; Ernesto Bonilla; Luz Marina Espina; Leonor Chacin-Bonilla; Florencio Añez; Mery Maldonado; Eddy Meleán
Journal:  Neurochem Res       Date:  2008-07-02       Impact factor: 3.996

6.  Inflammatory status and kynurenine metabolism in rheumatoid arthritis treated with melatonin.

Authors:  Caroline M Forrest; Gillian M Mackay; Nicholas Stoy; Trevor W Stone; L Gail Darlington
Journal:  Br J Clin Pharmacol       Date:  2007-05-15       Impact factor: 4.335

7.  Assessment of the Potential Role of Tryptophan as the Precursor of Serotonin and Melatonin for the Aged Sleep-wake Cycle and Immune Function: Streptopelia Risoria as a Model.

Authors:  Sergio D Paredes; Carmen Barriga; Russel J Reiter; Ana B Rodríguez
Journal:  Int J Tryptophan Res       Date:  2009-01-14

Review 8.  Melatonin in Early Treatment for COVID-19: A Narrative Review of Current Evidence and Possible Efficacy.

Authors:  Kristina M Cross; Dylan M Landis; Laveena Sehgal; J Drew Payne
Journal:  Endocr Pract       Date:  2021-06-10       Impact factor: 3.443

Review 9.  Melatonin: buffering the immune system.

Authors:  Antonio Carrillo-Vico; Patricia J Lardone; Nuria Alvarez-Sánchez; Ana Rodríguez-Rodríguez; Juan M Guerrero
Journal:  Int J Mol Sci       Date:  2013-04-22       Impact factor: 5.923

Review 10.  Melatonin and viral infections.

Authors:  Ernesto Bonilla; Nereida Valero; Leonor Chacín-Bonilla; Shirley Medina-Leendertz
Journal:  J Pineal Res       Date:  2004-03       Impact factor: 13.007

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.